BRPI0717150A8 - USES OF MESENCHYMAL STEM CELLS - Google Patents

USES OF MESENCHYMAL STEM CELLS

Info

Publication number
BRPI0717150A8
BRPI0717150A8 BRPI0717150A BRPI0717150A BRPI0717150A8 BR PI0717150 A8 BRPI0717150 A8 BR PI0717150A8 BR PI0717150 A BRPI0717150 A BR PI0717150A BR PI0717150 A BRPI0717150 A BR PI0717150A BR PI0717150 A8 BRPI0717150 A8 BR PI0717150A8
Authority
BR
Brazil
Prior art keywords
stem cells
mesenchymal stem
animal
promoting
organ
Prior art date
Application number
BRPI0717150A
Other languages
Portuguese (pt)
Inventor
Pittenger Mark
Aggarwal Sudeepta
Varney Timothy
Original Assignee
Osiris Therapeutics Inc
Mesoblast Int Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/541,853 external-priority patent/US20080213227A1/en
Application filed by Osiris Therapeutics Inc, Mesoblast Int Sarl filed Critical Osiris Therapeutics Inc
Publication of BRPI0717150A2 publication Critical patent/BRPI0717150A2/en
Publication of BRPI0717150A8 publication Critical patent/BRPI0717150A8/en
Publication of BRPI0717150B1 publication Critical patent/BRPI0717150B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

USOS DE CÉLULAS-TRONCO MESENQUIMAIS. A presente invenção refere-se a métodos de tratar doenças autoimunes, respostas alérgicas, câncer, ou doenças inflamatórias em um animal, promover a cicatrização da ferida, restaurar o dano epitelial e promover a angiogênese em um órgão ou tecido de um animal, por administração ao animal de células-tronco mesenquimais em uma quantidade eficaz.USES OF MESENCHYMAL STEM CELLS. The present invention relates to methods of treating autoimmune diseases, allergic responses, cancer, or inflammatory diseases in an animal, promoting wound healing, restoring epithelial damage, and promoting angiogenesis in an organ or tissue of an animal, by administering to the animal of mesenchymal stem cells in an effective amount.

BRPI0717150-1A 2006-10-02 2007-09-26 Uses of mesenchymal stem cells BRPI0717150B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1/541,853 2006-10-02
US11/541,853 2006-10-02
US11/541,853 US20080213227A1 (en) 2004-03-22 2006-10-02 Mesenchymal stem cells and uses therefor
PCT/US2007/020724 WO2008042174A2 (en) 2004-03-22 2007-09-26 Mesenchymal stem cells and uses therefor

Publications (3)

Publication Number Publication Date
BRPI0717150A2 BRPI0717150A2 (en) 2013-10-15
BRPI0717150A8 true BRPI0717150A8 (en) 2015-08-25
BRPI0717150B1 BRPI0717150B1 (en) 2022-04-19

Family

ID=49320923

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0717150-1A BRPI0717150B1 (en) 2006-10-02 2007-09-26 Uses of mesenchymal stem cells

Country Status (3)

Country Link
JP (1) JP2014139214A (en)
KR (9) KR20200124766A (en)
BR (1) BRPI0717150B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6452107B2 (en) 2014-09-05 2019-01-16 国立大学法人 東京大学 Pluripotent stem cells for the treatment of diabetic skin ulcers
WO2019146131A1 (en) * 2018-01-24 2019-08-01 学校法人順天堂大学 Composition for amplifying effect of treatment with mesenchymal stem cells
JPWO2021210515A1 (en) * 2020-04-13 2021-10-21

Also Published As

Publication number Publication date
KR101577553B1 (en) 2015-12-14
KR20230008250A (en) 2023-01-13
KR20170132344A (en) 2017-12-01
KR20240027136A (en) 2024-02-29
KR20160092038A (en) 2016-08-03
JP2014139214A (en) 2014-07-31
KR20200124766A (en) 2020-11-03
BRPI0717150A2 (en) 2013-10-15
KR20140061517A (en) 2014-05-21
KR20150021588A (en) 2015-03-02
KR20150103331A (en) 2015-09-09
BRPI0717150B1 (en) 2022-04-19
KR20210138808A (en) 2021-11-19

Similar Documents

Publication Publication Date Title
BRPI0802241A2 (en) mesenchymal stem cells and their uses
WO2008042174A3 (en) Mesenchymal stem cells and uses therefor
AR061171A1 (en) PROTEINS OF UNION TO THE GROWTH FACTOR OF HEPATOCITS (FCH)
AR061170A1 (en) PROTEINS THAT JOIN THE HEPATOCITE GROWTH FACTOR (HGF)
DE502005010615D1 (en) MEDICINE FOR THE TREATMENT OF INFLAMMATORY DISEASES
CO6640289A2 (en) Compositions of anti-nerve growth factor antibodies (ngf)
BR112014018421A8 (en) ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA AND/OR 15-HETRE AND METHODS OF USE THEREOF
BRPI1011710A8 (en) artificial tears and traumatic uses
HK1205531A1 (en) Mesenchymal stem cells and uses therefor
CO6680687A2 (en) Dual variable domain immunoglobins capable of binding to il 1 beta and il-17, pharmaceutical compositions and protein binding conjugates thereof
BRPI0925036B8 (en) use of trans-t-butyl cyclohexanol, cosmetic composition, medicine, its uses and processes to treat skin irritation
AR084373A1 (en) COMPOSITIONS AND METHODS FOR THE ELIMINATION OF BIOPELLICLES
BR112013007314A2 (en) anti-cd48 antibodies and their uses
CO6351742A2 (en) ORGANIC COMPOUNDS FOR WOUND CICATRIZATION
GT200900095A (en) REPLACED DIHYDROPIRAZOLONES FOR THE TREATMENT OF CARDIOVASCULAR AND HERMATOLOGICAL DISEASES.
TW200732347A (en) VEGF analogs and methods of use
CR9949A (en) 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITORS (FLAP)
BR112014006455A2 (en) alkylamidothiazoles, cosmetic or dermatological preparations having a content of one or more alkylamidothiazoles and use of one or more alkylamidothiazoles
BR112017017599A2 (en) methods for modulating immune and inflammatory responses by administering an algal biomass
IN2014DN08440A (en)
BR112013010325A2 (en) compositions for treating peripheral ulcers of various origins
DE602006011959D1 (en) NA +, K + -ATPASE EXPRESSION IN ZERVIX DYSPLASIA AND CANCER
DK1988909T3 (en) Use of polyethylene glycol for inflammation-related topical disorders or diseases and wound healing
BRPI0800085A2 (en) pharmaceutical composition and dressing for the treatment of skin lesions, as well as the use of cerium salt associated with a collagen matrix
BRPI0717150A8 (en) USES OF MESENCHYMAL STEM CELLS

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: MESOBLAST INTERNATIONAL SARL (CH)

B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 3A E 4A ANUIDADES.

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C12N 5/00, C12N 5/16

Ipc: A61K 35/28 (2006.01), A61P 29/00 (2006.01), A61P 3

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/09/2007, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.